Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mohamed F.K. Ibrahim"'
Autor:
Ricardo Fernandes, Sasha Mazzarello, Carol Stober, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Lisa Vandermeer, Risa Shorr, Brian Hutton, Dean Fergusson, Bishal Gyawali, Mark Clemons
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-8 (2017)
Purpose: Despite widespread use of fluorouracil, epirubicin, cyclophosphamide, docetaxel (FEC-D) chemotherapy in breast cancer, the optimal strategy for primary febrile neutropenia (FN) prophylaxis remains unknown. A systematic review was therefore p
Externí odkaz:
https://doaj.org/article/9e554e5a51804a4eb5a50e5161a17dca
Autor:
M. Bahl, Demetrios Simos, Ricardo Fernandes, Jacques Raphael, Nadia Califaretti, Brian Hutton, L. Zibdawi, Carol Stober, Mark Clemons, Ranjeeta Mallick, Deanna Saunders, Andrew Robinson, Lacey D. Pitre, Mohamed F.K. Ibrahim, John Hilton, Dean Fergusson, Olexiy Aseyev, Arif Awan, Lisa Vandermeer, Gregory R. Pond, M. Mates
Publikováno v:
Annals of Oncology
Background The optimal duration of filgrastim as primary febrile neutropenia (FN) prophylaxis in early breast cancer patients is unknown, with 5, 7 or 10 days being commonly prescribed. This trial evaluates whether 5 days of filgrastim was non-inferi
Autor:
Lisa Vandermeer, Kirstin Perdrizet, Mark Clemons, Dean Fergusson, Mohamed F.K. Ibrahim, Risa Shorr, Brian Hutton, Shaan Dudani, Bishal Gyawali, Ricardo Fernandes, Carol Stober, Sasha Mazzarello, Habeeb Majeed
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-8 (2017)
Journal of Global Oncology
Journal of Global Oncology
Purpose Despite widespread use of fluorouracil, epirubicin, cyclophosphamide, docetaxel (FEC-D) chemotherapy in breast cancer, the optimal strategy for primary febrile neutropenia (FN) prophylaxis remains unknown. A systematic review was therefore pe
Autor:
Brian Hutton, Carol Stober, Ricardo Fernandes, Risa Shorr, Dean Fergusson, Lisa Vandermeer, Shaan Dudani, Mark Clemons, Mohamed F.K. Ibrahim, Kirstin Perdrizet, Sasha Mazzarello, Habeeb Majeed
Publikováno v:
Breast Cancer Research and Treatment. 161:1-10
Due to the high rate of febrile neutropenia (FN) with docetaxel-cyclophosphamide (DC) chemotherapy, primary FN prophylaxis is recommended. However, the optimal choice of prophylaxis [i.e., granulocyte-colony stimulating factors (G-CSF) or antibiotics
Autor:
Carol Stober, Brian Hutton, M.A.G. Lima, Marta Sienkiewicz, Lisa Vandermeer, Mohamed F.K. Ibrahim, Sharon F. McGee, Mark Clemons, Risa Shorr, Dean Fergusson, Sasha Mazzarello, John Hilton, Jean-Michel Caudrelier, Ricardo Fernandes
Publikováno v:
Cancer treatment reviews. 69
Importance Clinical equipoise exists around the optimal time to start adjuvant endocrine therapy in patients who will receive post-operative radiotherapy for breast cancer. Concerns continue to exist regarding potential reduced efficacy, or increased
Autor:
Mark Clemons, C. Stober, Michael Ong, Christina Canil, John Hilton, Brian Hutton, Lisa Vandermeer, Sasha Mazzarello, Sambasivarao Damaraju, Anil A. Joy, M. da Costa, Ricardo Fernandes, Mohamed F.K. Ibrahim, Gregory R. Pond
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 26(9)
Taxane acute pain syndrome (TAPS) is characterized by myalgias and arthralgias starting 2–3 days after taxane-based chemotherapy and lasting up to 7 days. In the absence of validated tools, many studies use the presence of both the myalgia and arth
Autor:
Stephanie Smith, Brian Hutton, Demetrios Simos, Ian D. Graham, Christina L. Addison, Angel Arnaout, Mark Clemons, Carmel Jacobs, Mohamed F.K. Ibrahim, Jean-Michel Caudrelier
Publikováno v:
Journal of Evaluation in Clinical Practice. 21:740-748
Rationale, aims and objectives Invasive lobular breast cancer (ILC) has distinct features that present challenges for management. We surveyed doctors regarding management approaches, opinions on quality of evidence supporting their practice, and futu
Autor:
Mark Clemons, Carmel Jacobs, Jean-Michel Caudrelier, Mohamed F.K. Ibrahim, Brain Hutton, Angel Arnaout, Ian D. Graham, Christina L. Addison
Publikováno v:
Cancer Research. 75:P5-21
Introduction: Invasive lobular carcinoma (ILC) is common and accounts for 5-15% of all breast cancers. ILC has distinct clinical and histological features that separate it from invasive ductal carcinoma (IDC) with regards to its breast imaging charac
Autor:
Brian Hutton, Mohamed F.K. Ibrahim, Lisa Vandermeer, John Hilton, Risa Shorr, Mark Clemons, Sasha Mazzarello
Publikováno v:
Journal of Clinical Oncology. 33:e17711-e17711
e17711 Should de-escalation of bone-targeted agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis Background: De-escalation of bone...
Autor:
Fernandes R; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Mazzarello S; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Stober C; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Ibrahim MFK; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Dudani S; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Perdrizet K; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Majeed H; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Vandermeer L; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Shorr R; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Hutton B; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Fergusson D; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Gyawali B; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal., Clemons M; Ricardo Fernandes, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, and Risa Shorr, The Ottawa Hospital; Ricardo Fernandes, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Brian Hutton, Dean Fergusson, and Mark Clemons, University of Ottawa; Sasha Mazzarello, Carol Stober, Lisa Vandermeer, Brian Hutton, Dean Fergusson, and Mark Clemons, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Bishal Gyawali, Nobel Hospital, Sinamangal, Kathmandu, Nepal.
Publikováno v:
Journal of global oncology [J Glob Oncol] 2018 Sep; Vol. 4, pp. 1-8. Date of Electronic Publication: 2017 Apr 21.